We are live on
!
Find out more
Arrowstreet Capital Portfolio holdings
AUM
$185B
1-Year Est. Return
39.58%
This Fund
S&P 500
This Quarter
Est. Return
+1.19%
1 Year Est. Return
+39.58%
3 Year Est. Return
+145.48%
5 Year Est. Return
+192.07%
10 Year Est. Return
+749.68%
AUM
$17.7B
AUM Growth
+$1.44B
(+8.9%)
Cap. Flow
+$1.58B
Cap. Flow
% of AUM
8.95%
Top 10 Holdings %
Top 10 Hldgs %
19.92%
Holding
1,403
New
439
Increased
358
Reduced
346
Closed
241
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$403M |
| 2 |
Walt Disney
DIS
|
+$157M |
| 3 |
CELG
Celgene Corp
CELG
|
+$141M |
| 4 |
Citigroup
C
|
+$137M |
| 5 |
Starbucks
SBUX
|
+$132M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Union Pacific
UNP
|
+$244M |
| 2 |
TWC
TIME WARNER CABLE INC NEW COM STK
TWC
|
+$178M |
| 3 |
Canadian National Railway
CNI
|
+$146M |
| 4 |
AT&T
T
|
+$139M |
| 5 |
Micron Technology
MU
|
+$134M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.11% |
| 2 | Financials | 17.79% |
| 3 | Healthcare | 17.78% |
| 4 | Consumer Staples | 7.98% |
| 5 | Consumer Discretionary | 7.77% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
251
Zoetis
ZTS
$31.8B
| $10.9M | 0.06% |
226,321
+196,300
| +654% | +$9.37M |
|
252
Novartis
NVS
$297B
| $10.9M | 0.06% |
123,541
+40,845
| +49% | +$3.75M |
|
253
Royal Bank of Canada
RY
$293B
| $10.8M | 0.06% |
177,000
+158,225
| +843% | +$10.2M |
|
|
POLY
254
DELISTED
Plantronics, Inc.
POLY
| $10.7M | 0.06% |
190,304
+20,651
| +12% | +$1.15M |
|
|
INFN
255
DELISTED
Infinera Corporation Common Stock
INFN
| $10.6M | 0.06% |
+506,447
| New | +$10.3M |
|
256
Cleveland-Cliffs
CLF
$6.95B
| $10.6M | 0.06% |
+2,452,685
| New | +$13M |
|
257
Vale
VALE
$63B
| $10.6M | 0.06% |
1,797,486
+1,758,186
| +4,474% | +$11.8M |
|
|
STRZA
258
DELISTED
Starz - Series A
STRZA
| $10.6M | 0.06% |
236,079
+137,271
| +139% | +$5.46M |
|
259
Comscore
SCOR
$109M
| $10.5M | 0.06% |
9,849
+4,739
| +93% | +$5.12M |
|
260
Berkshire Hathaway Class A
BRK.A
$1.12T
| $10.4M | 0.06% |
+51
| New | +$10.9M |
|
|
RGC
261
DELISTED
Regal Entertainment Group
RGC
| $10.3M | 0.06% |
494,842
-501,072
| -50% | -$10.8M |
|
262
Commerce Bancshares
CBSH
$8.51B
| $10.3M | 0.06% |
+375,231
| New | +$9.73M |
|
263
Seagate
STX
$175B
| $10.2M | 0.06% |
214,489
+22,700
| +12% | +$1.25M |
|
|
THOR
264
DELISTED
THORATEC CORPORATION
THOR
| $10.1M | 0.06% |
225,706
+211,800
| +1,523% | +$9.27M |
|
265
Broadcom
AVGO
$2.03T
| $10M | 0.06% |
+755,000
| New | +$9.89M |
|
|
CHU
266
DELISTED
China Unicom (HONG KONG) Limited
CHU
| $9.98M | 0.06% |
635,731
-586,738
| -48% | -$10.3M |
|
|
MRO
267
DELISTED
Marathon Oil Corporation
MRO
| $9.96M | 0.06% |
375,282
-21,600
| -5% | -$610K |
|
268
Adtran
ADTN
$608M
| $9.95M | 0.06% |
612,108
+121,060
| +25% | +$2.08M |
|
269
TSMC
TSM
$2.16T
| $9.93M | 0.06% |
437,433
-2,037,388
| -82% | -$48.6M |
|
270
Pearson
PSO
$9.99B
| $9.9M | 0.06% |
522,156
-65,336
| -11% | -$1.33M |
|
271
Illinois Tool Works
ITW
$85.4B
| $9.88M | 0.06% |
+107,600
| New | +$10.2M |
|
|
ARGO
272
DELISTED
Argo Group International Holdings, Ltd.
ARGO
| $9.84M | 0.06% |
223,428
+164,929
| +282% | +$6.84M |
|
|
BT
273
DELISTED
BT Group plc (ADR)
BT
| $9.82M | 0.06% |
+277,198
| New | +$9.68M |
|
|
PTR
274
DELISTED
PETROCHINA COMPANY LIMITED ADS (REP 100 H SHARES)
PTR
| $9.82M | 0.06% |
+88,643
| New | +$10.8M |
|
275
America Movil
AMX
$71.6B
| $9.67M | 0.05% |
+453,844
| New | +$9.56M |
|
Similar funds
VGA
Arrowstreet Capital's Q2 2015 Portfolio in Review
As of Q2 2015, Arrowstreet Capital held 1,403 positions worth $17.7B, up 8.9% from $16.2B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Arrowstreet Capital deployed $1.58B of net new capital in Q2 2015, opening 439 new positions and adding to 358 existing holdings. Its largest new stake was Teva Pharmaceuticals: 1,922,584 shares worth $114M.
By sector, the portfolio is most concentrated in Technology at 24% of assets, down from 29% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Union Pacific, an estimated $244M trimmed.
- Arrowstreet Capital's largest Q2 2015 buy was Teva Pharmaceuticals: 1,922,584 shares worth $114M.
- Arrowstreet Capital added most to Apple in Q2 2015, an estimated $403M increase.
- Arrowstreet Capital's biggest Q2 2015 reduction was Union Pacific, cutting an estimated $244M.
- Arrowstreet Capital fully exited Canadian National Railway in Q2 2015, selling an estimated $146M.
- Arrowstreet Capital's ten largest holdings make up 20% of its $17.7B portfolio in Q2 2015.
- Arrowstreet Capital opened 439 new positions and closed 241 in Q2 2015.
- Arrowstreet Capital's portfolio value rose 8.9% quarter-over-quarter to $17.7B.
Based on Arrowstreet Capital's 13F filing for Q2 2015, filed 13 Aug 2015.